Karakteristik Central Serous Chorioretinopathy di Pusat Mata Nasional Rumah Sakit Mata Cicendo Tahun 2016

Ahmad Ikliluddin

Abstract


Central serous chorioretinopathy (CSC) merupakan penyakit pada retina yang ditandai oleh terjadinya ablasi serosa dari lapisan neurosensori retina yang diakibatkan oleh gangguan pada lapisan retinal pigmen epithelium (RPE). CSC kebanyakan terjadi pada usia pertengahan dan lebih sering terjadi pada pria dibanding wanita. Gejala utama adalah penglihatan kabur, biasanya terjadi pada satu mata dan dirasakan pasien sebagai bayangan hitam yang menghalangi penglihatan yang berhubungan dengan mikropsia atau metamorfsia. Tujuan penelitian ini untuk mendapatkan gambaran mengenai karakteristik pasien yang terdiagnosis CSC dan jenis terapi yang diberikan di Pusat Mata Nasional Rumah Sakit Mata Cicendo, pada periode Januari 2016 – Desember 2016. Penelitian dilakukan menggunakan metode deskriptif dengan desain hospital based study. Populasi penelitian ini adalah semua pasien berobat di poli mata Rumah Sakit Mata Cicendo selama periode penelitian. Data yang dikumpulkan adalah data sekunder yang diperoleh dari status pasien yang terdiagnosis CSC. Karakteristik pasien CSC yang didapatkan paling banyak adalah laki-laki (71,97%), usia 40-49 tahun (43,18%), dengan visus awal saat kedatangan pada rentang 0,4 logMAR - 0,1 logMAR (53,57%). Keterlibatan mata terbanyak bersifat unilateral (93,93%), dengan rerata ketebalan subfovea sentralis saat kedatangan adalah 402,33µm.

Central serous chorioretinopathy (CSC) is a disease of the retina characterized by serous detachment of the retinal neurosensory caused by impairment of the retinal pigment epithelium (RPE). CSC mostly occurs in middle age and more common in men than women. The main symptom is blurred vision, usually occurring unilateral and perceived as a black shadow that blocks vision associated with micropsia or metamorphsia. The purpose of this study was to obtain the characteristics of patients diagnosed with CSC and the type of therapy at Cicendo Eye Hospital, at January 2016 - December 2016. The study was conducted using descriptive method with the design of hospital based study. The population of this study were all patients treated at Cicendo Eye Hospital during the study period. The data collected were secondary data obtained from the medical record of patients diagnosed with CSC. The most common characteristics of CSC patients were men (71.97%), 40-49 years of age (43.18%), with initial visual acuity at arrival was 0.4 logMAR - 0.1 logMAR (53.57 %). Most eye involvement was unilateral (93.93%), with mean central subfoveal thickness at arrival is 402.33µm

Keywords


Central serous chorioretinopathy; serous detachment; optical coherrence tomography; angiography OCT; enhanced-depth imaging; Central serous chorioretinopathy; ablasi serosa; optical coherrence tomography; OCT angiography enhanced-depth imaging

Full Text:

PDF

References


Von Graefe A. Ueber Central Recidivierende Retinitis. Graefes Arch Clin Exp Ophthalmol 1866; 12: 211-5

Maria Wang, Inger Munch, Pascal W Hasler, Christian Prunte, Michael Larsen. Central Serous Chorioretinopathy. Acta Ophthalmol 2008; 86; 126-45

Ross A, Ross AH, Mohammed Q. Review and Update of Central Serous Chorioretinopathy. Curr Opin Ophthalmol 2011; 22 (3): 166-73

Wang MS, Sander B, Larsen M. Retinal Atrophy in Idiopathic Central Serous Chorioretinopathy. Am J Ophthamol 2002; 133: 787-793

Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A. The Foveal Photoreceptor Layer and Visual Acuity Loss in Central Serous Chorioretinopathy. Am J Ophthalmol 2005; 139: 87-99

David T Liu, Andrew C Fok, Waiman Chan, Timothy Y Lai, Dennis S Lam. Central Serous Chorioretinopathy. Retina 2013; 72: 1291-1303

Bujarborua D, Nagpal PN, Deka M. Smokestack Leak in Central Serous Chorioretinopathy. Graefes Aerch Clin Exp Ophthalmol 2010; 248: 33951

Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical Coherence Tomography. Science 1991; 254: 1178-81

Hee MR, Puliafito CA, Wong C, Reichel E, Duker JS, Schuman JS, et al. Optical Coherence Tomography of Central Serous Chorioretinopathy. Am J Ophthalmol 1995; 120: 65-74

Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous Chorioretinopathy: Update on Pathophysiology and Treatment. Surv Ophthalmol 2013; 58: 103-26

Errera MH, Kohly RP, Cruz L. Pregnancy Associated Retinal Diseases and Their Management. Surv Ophthalmol 2013; 58; 127-42

Eom Y, Oh J, Kim SW, Huh K. Systemic Factors Associated with Central Serous Chorioretinopathy in Koreans. Korean J Ophthalmol 2012; 26: 260-4

Aamir A, Bisma I, Hina K, Maha A. Choroidal Thickness in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy. Adv Ophthalmol Vis Syst 2016; 4: 1-5

Yanuzzi LA. Central Serous Chorioretinopathy: A Personal Perspective. Am J Ophthalmol 2010; 149: 361-3

Aggio FB, Roisman L, Melo GB, Lavinsky D, Cardillo JA, Farah ME. Clinical Factors Related to Visual Outcome in Central Serous Chorioretinopathy. Retina 2010; 30: 1128-34

Gass JD. Pathogenesis of Disciform Detachment of the Neuroepithelium. Am J Ophthalmol 1976; 63: 1-139

Bae SH, Heo JW, Kim TW, Lee JY, Song SJ, Park TK, et al. Randomized Pilot Study of LowFluence Photo Dinamic Therapy Versus Intravitreal Ranibizumab for Chronic Central Serous Chorioretinopathy. Am J Ophthalmol 2011; 152: 784-92

Schaal KB, Hoeh AE, Scheuerle A, Schuett F, Dithmar S. Intravitreal Bevacizumab for Treatment of Chronic Central Serous Chorioretinopathy. Eur J Ophthalmol 2009; 19: 613-7

Lim SJ, Roh MI, Kwon OW. Intravitreal Bevacizumab Injection for Central Serous Chorioretinopathy. Retina 2010; 39: 100-16


Refbacks

  • There are currently no refbacks.




Office:
Faculty of Medicine and Health Science Universitas Muhammadiyah Yogyakarta,
Gedung G1 (Biomedik) Lantai Dasar, FKIK UMY, Phone: +62 274 387 656 (ext: 231)
Jalan Lingkar Selatan, Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta, Indonesia
Website: http://journal.umy.ac.id/index.php/mm - E-mail: jmmfkik@umy.ac.id

View My Stats